VentriPoint Diagnostics Ltd (V:VPT) — Stock Price
VentriPoint Diagnostics Ltd (V:VPT) is currently trading at CA$0.10 CAD, up 0.00% today. Over the past 52 weeks, shares have ranged between CA$0.08 and CA$0.17. This page tracks VentriPoint Diagnostics Ltd's live share price on the V exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see VentriPoint Diagnostics Ltd market capitalisation.
VentriPoint Diagnostics Ltd (VPT) Stock Price Chart — Daily History & Trading Volume
The chart below tracks VentriPoint Diagnostics Ltd's daily closing share price and trading volume on the V exchange over the past year, giving a clear view of recent price momentum and liquidity.
VentriPoint Diagnostics Ltd Income Statement — Revenue, Profit & Earnings by Year
VentriPoint Diagnostics Ltd's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Total Revenue | CA$95.17K | CA$49.18K | CA$68.17K | CA$0.00 | CA$36.02K |
| Cost of Revenue | CA$0.00 | CA$73.42K | CA$10.36K | CA$48.81K | CA$9.75K |
| Gross Profit | CA$95.17K | CA$-24.23K | CA$57.81K | CA$-48.81K | CA$26.27K |
| Research & Development | CA$969.24K | CA$1.08 Million | CA$1.05 Million | CA$457.34K | CA$272.04K |
| SG&A | CA$3.93 Million | CA$2.81 Million | CA$3.06 Million | CA$2.67 Million | CA$1.49 Million |
| Total Operating Expenses | CA$4.90 Million | CA$4.91 Million | CA$4.97 Million | CA$3.72 Million | CA$1.92 Million |
| Operating Income | CA$-4.80 Million | CA$-4.93 Million | CA$-4.91 Million | CA$-3.72 Million | CA$-1.89 Million |
| EBITDA | — | CA$-4.86 Million | CA$-4.73 Million | CA$-3.54 Million | CA$-1.59 Million |
| EBIT | — | CA$-4.93 Million | CA$-4.78 Million | CA$-3.59 Million | CA$-1.65 Million |
| Interest Expense | CA$179.72K | CA$58.43K | CA$28.16K | CA$12.96K | CA$229.31K |
| Income Before Tax | CA$-5.00 Million | CA$-4.87 Million | CA$-4.87 Million | CA$-3.88 Million | CA$-1.85 Million |
| Income Tax Expense | — | CA$3.00 | CA$136.05K | CA$92.93K | CA$463.50K |
| Net Income | CA$-4.92 Million | CA$-4.87 Million | CA$-4.87 Million | CA$-3.88 Million | CA$-1.85 Million |
VentriPoint Diagnostics Ltd Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes VentriPoint Diagnostics Ltd's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Total Assets | CA$658.02K | CA$1.88 Million | CA$5.98 Million | CA$9.54 Million | CA$801.57K |
| Total Current Assets | CA$474.30K | CA$1.64 Million | CA$5.66 Million | CA$9.50 Million | CA$714.50K |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | — | — | — | — | — |
| Net Receivables | CA$27.68K | CA$285.50K | CA$374.18K | CA$197.49K | CA$165.34K |
| Inventory | — | — | — | — | CA$0.00 |
| Property, Plant & Equipment | — | — | — | — | CA$87.08K |
| Goodwill | — | — | — | — | — |
| Total Liabilities | CA$3.64 Million | CA$1.69 Million | CA$1.42 Million | CA$1.21 Million | CA$3.15 Million |
| Total Current Liabilities | CA$3.43 Million | CA$1.40 Million | CA$1.06 Million | CA$1.09 Million | CA$1.82 Million |
| Long-term Debt | CA$58.78K | CA$77.63K | CA$93.06K | CA$125.38K | CA$1.29 Million |
| Net Debt | CA$1.35 Million | CA$-1.02 Million | CA$-4.73 Million | CA$-9.11 Million | CA$843.84K |
| Total Stockholder Equity | CA$-2.98 Million | CA$189.71K | CA$4.55 Million | CA$8.33 Million | CA$-2.35 Million |
| Retained Earnings | CA$-58.41 Million | CA$-53.49 Million | CA$-48.62 Million | CA$-43.75 Million | CA$-39.87 Million |
VentriPoint Diagnostics Ltd Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how VentriPoint Diagnostics Ltd generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Cash Flow | CA$-3.39 Million | CA$-3.80 Million | CA$-4.14 Million | CA$-3.15 Million | CA$-1.10 Million |
| Capital Expenditures | CA$0.00 | CA$0.00 | CA$0.00 | CA$4.26K | CA$3.76K |
| Free Cash Flow | CA$-3.39 Million | CA$-3.80 Million | CA$-4.14 Million | CA$-3.15 Million | CA$-1.10 Million |
| Investing Cash Flow | — | — | — | — | CA$-3.76K |
| Financing Cash Flow | CA$2.20 Million | CA$-102.36K | CA$87.65K | CA$11.89 Million | CA$1.62 Million |
| Dividends Paid | CA$0.00 | CA$0.00 | — | — | CA$0.00 |
| Stock-Based Compensation | CA$684.46K | CA$493.30K | CA$798.05K | CA$898.30K | CA$394.85K |
| Depreciation | CA$62.87K | CA$66.67K | CA$50.90K | CA$48.81K | CA$54.94K |
| Change in Cash | CA$-1.23 Million | CA$-3.89 Million | CA$-4.08 Million | CA$8.74 Million | CA$512.26K |
VentriPoint Diagnostics Ltd Earnings History — EPS Actual vs. Analyst Estimates
Track VentriPoint Diagnostics Ltd's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| May 29, 2026 | — | — | — |
| Nov 28, 2025 | — | — | — |
| Aug 29, 2025 | — | — | — |
| May 30, 2025 | — | — | — |
| Nov 27, 2024 | — | — | — |
| Jun 01, 2023 | -0.01 | — | — |
| Dec 31, 2022 | -0.01 | — | — |
| Nov 29, 2022 | -0.01 | — | — |